tiprankstipranks
Rapt Therapeutics reports Q4 EPS (80c), consensus (86c)
PremiumThe FlyRapt Therapeutics reports Q4 EPS (80c), consensus (86c)
2M ago
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
2M ago
Rapt Therapeutics Inc (RAPT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Rapt Therapeutics Inc (RAPT) Q4 Earnings Cheat Sheet
2M ago
Rapt Therapeutics price target lowered to $32 from $42 at Wells Fargo
PremiumThe FlyRapt Therapeutics price target lowered to $32 from $42 at Wells Fargo
2M ago
Rapt Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Rapt Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
Rapt Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Rapt Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
RAPT Therapeutics (NASDAQ:RAPT) Crashes 60% after FDA Places Clinical Hold
PremiumMarket NewsRAPT Therapeutics (NASDAQ:RAPT) Crashes 60% after FDA Places Clinical Hold
2M ago
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
PremiumPress Releases
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
2M ago
Rapt Therapeutics announces clinical hold on studies evaluating zelnecirnon
PremiumThe Fly
Rapt Therapeutics announces clinical hold on studies evaluating zelnecirnon
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100